Opportunity Information: Apply for PAR 12 063
Apply for PAR 12 063
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Research Dissemination and Implementation Grants (R18)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.233 National Center on Sleep Disorders Research 93.837 Cardiovascular Diseases Research 93.838 Lung Diseases Research 93.839 Blood Diseases and Resources Research.
- This funding opportunity was created on Dec 16, 2011 and posted on Dec 16, 2011.
- Applicants must submit their applications by May 7, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal organizations (other than Federally recognized tribal governments) State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Independent school districts City or township governments Public housing authorities/Indian housing authorities Small businesses Native American tribal governments (Federally recognized) For profit organizations other than small businesses County governments Special district governments Public and State controlled institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Research Dissemination and Implementation Grants (R18) funding opportunity (PAR 12-063) is a National Institutes of Health (NIH) discretionary grant program in the health category designed to move proven interventions for heart, lung, and blood diseases and sleep disorders out of controlled research environments and into real-world practice. The central idea is to close the gap between what is known to work (efficacious treatments and effective prevention approaches) and what is routinely delivered in clinics, communities, and other everyday settings where people actually receive care and prevention services. Rather than funding early-stage discovery or tightly controlled efficacy trials, this opportunity focuses on the practical science of dissemination and implementation, meaning the strategies and conditions that help evidence-based interventions get adopted, delivered with quality, sustained over time, and scaled in ways that produce measurable health benefit.
The FOA supports three main types of work. First, it encourages the development of innovative approaches to translating established, evidence-based treatments and prevention modalities into real-world settings. This can include creating or adapting implementation strategies, developing training or workflow supports, building partnerships with community or clinical organizations, and tailoring delivery models so that interventions fit the realities of staffing, resources, culture, and patient needs without undermining core effective elements. Second, it supports studies that test how well these dissemination and implementation approaches work in practice, with emphasis on outcomes such as effectiveness in real-world conditions, sustainability over time, determinants of successful or unsuccessful implementation (for example, organizational readiness, leadership support, reimbursement constraints, patient access barriers, or fidelity challenges), and cost-effectiveness. Third, it allows researchers to examine how interventions perform as they are actually disseminated and implemented, with the goal of reducing risk factors and improving prevention and treatment for the targeted conditions. In other words, the program is concerned both with the outcomes of implementation strategies and with the health and behavioral outcomes that result when interventions reach real populations.
From an administrative standpoint, this is an NIH grant mechanism using the R18 activity code, and it falls under multiple CFDA numbers reflecting the program areas it touches, including cardiovascular diseases research (93.837), lung diseases research (93.838), blood diseases and resources research (93.839), and the National Center on Sleep Disorders Research (93.233). The announcement was posted and created on December 16, 2011, with an original and current closing date of May 7, 2013, and an archive date of June 7, 2013. The opportunity does not require cost sharing or matching, which can make budgeting and participation more straightforward for applicants.
Eligibility is broad across public and private sectors, reflecting the real-world nature of dissemination and implementation work. Eligible applicants include state, county, city or township, and special district governments; federally recognized tribal governments and other tribal organizations; public and state-controlled institutions of higher education as well as private institutions of higher education; independent school districts; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); small businesses; and for-profit organizations other than small businesses. The FOA also explicitly includes a range of other eligible organizations such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), tribally controlled colleges and universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal government agencies, and U.S. territories or possessions. At the same time, it clearly excludes non-U.S. (foreign) institutions, non-U.S. components of U.S. organizations, and foreign components as defined by the NIH Grants Policy Statement, meaning the proposed work must be anchored within eligible domestic entities.
Overall, the grant opportunity is aimed at improving public health impact by funding research that tackles the practical barriers to getting evidence-based prevention and treatment used consistently and effectively in everyday settings. Projects under this FOA would be expected to generate actionable knowledge about what implementation approaches work, in which contexts, at what cost, and with what level of durability, while keeping the ultimate focus on reducing risk and improving outcomes for heart, lung, blood, and sleep-related conditions. For the full archived announcement details, NIH provided the reference link at http://grants.nih.gov/grants/guide/pa-files/PAR-12-063.html, and technical access issues were directed to the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the Research Dissemination and Implementation Grants (R18) opportunity (PAR 12-063)?
PAR 12-063 is an NIH discretionary grant opportunity using the R18 activity code. It supports research focused on dissemination and implementation (D&I) for proven interventions related to heart, lung, and blood diseases and sleep disorders, with the goal of moving what is known to work into routine real-world practice.
What is the main purpose of this funding opportunity?
The purpose is to close the gap between evidence-based interventions (efficacious treatments and effective prevention approaches) and what is routinely delivered in clinics, communities, and other everyday settings. The program emphasizes practical strategies that help interventions get adopted, implemented with quality, sustained over time, and scaled to produce measurable health benefit.
What kinds of research does this FOA prioritize?
This FOA prioritizes dissemination and implementation research rather than early-stage discovery or tightly controlled efficacy trials. It is centered on the practical science of how interventions are adopted and delivered in real-world systems and settings.
What are the three main types of work supported under this FOA?
The FOA supports: (1) developing innovative approaches for translating established evidence-based treatments and prevention modalities into real-world settings; (2) testing how well dissemination and implementation approaches work in practice (including sustainability, determinants, and cost-effectiveness); and (3) examining how interventions perform as they are disseminated and implemented, with the aim of improving prevention and treatment outcomes for the targeted conditions.
What does "dissemination and implementation" mean in the context of this grant?
In this context, dissemination and implementation refers to studying and improving the strategies and conditions that help evidence-based interventions get adopted, delivered with quality, sustained over time, and scaled in real-world environments (such as clinical and community settings).
Is this funding meant for discovering new treatments?
No. Based on the description provided, this opportunity is focused on moving established, evidence-based interventions into practice and studying how to do that effectively. It is not described as supporting early-stage discovery.
Is this funding meant for tightly controlled efficacy trials?
No. The opportunity is described as distinct from tightly controlled efficacy trials and instead emphasizes real-world implementation and dissemination outcomes.
What health areas and conditions are targeted by this FOA?
The targeted areas include heart, lung, and blood diseases and sleep disorders, with a focus on improving prevention and treatment impact in real populations.
What outcomes are emphasized when testing dissemination and implementation approaches?
Emphasized outcomes include real-world effectiveness, sustainability over time, determinants of successful or unsuccessful implementation (such as organizational readiness or reimbursement constraints), fidelity challenges, patient access barriers, leadership support, and cost-effectiveness.
What are examples of determinants or barriers the FOA is concerned with?
Examples specifically mentioned include organizational readiness, leadership support, reimbursement constraints, patient access barriers, and fidelity challenges (maintaining core effective elements while adapting to real settings).
What types of activities might be included under "developing innovative approaches" for real-world translation?
Examples described include creating or adapting implementation strategies, developing training or workflow supports, building partnerships with community or clinical organizations, and tailoring delivery models to fit staffing, resources, culture, and patient needs without undermining core effective elements.
Does the FOA support evaluating the health outcomes that result when interventions reach real populations?
Yes. The program is concerned both with implementation strategy outcomes and with the health and behavioral outcomes that result when evidence-based interventions are delivered to real-world populations.
What is the grant mechanism and activity code?
The mechanism uses the NIH R18 activity code.
Which CFDA numbers are associated with this opportunity?
The opportunity falls under multiple CFDA numbers reflecting the relevant program areas: 93.837 (cardiovascular diseases research), 93.838 (lung diseases research), 93.839 (blood diseases and resources research), and 93.233 (National Center on Sleep Disorders Research).
When was the announcement posted, and what were the closing and archive dates?
The announcement was posted and created on December 16, 2011. The original and current closing date was May 7, 2013. The archive date was June 7, 2013.
Is cost sharing or matching required?
No. The opportunity does not require cost sharing or matching.
Who is eligible to apply?
Eligibility is broad and includes many public and private organizations, such as state/county/city/township/special district governments; federally recognized tribal governments and other tribal organizations; public and state-controlled institutions of higher education; private institutions of higher education; independent school districts; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); small businesses; and for-profit organizations other than small businesses.
Are community-based and faith-based organizations eligible?
Yes. The FOA explicitly includes faith-based or community-based organizations among eligible applicants.
Are minority-serving institutions specifically included?
Yes. The FOA explicitly includes Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), and tribally controlled colleges and universities (TCCUs).
Are U.S. territories eligible?
Yes. U.S. territories or possessions are listed among eligible applicants.
Are federal agencies eligible to apply?
Yes. The FOA includes eligible federal government agencies among the eligible applicant types.
Are non-U.S. (foreign) institutions eligible?
No. The FOA excludes non-U.S. (foreign) institutions.
Are non-U.S. components of U.S. organizations allowed?
No. The FOA excludes non-U.S. components of U.S. organizations and foreign components as defined by the NIH Grants Policy Statement.
Where can applicants find the full archived announcement?
The NIH reference link provided for the archived announcement is: http://grants.nih.gov/grants/guide/pa-files/PAR-12-063.html
Who should be contacted for technical access issues related to the announcement?
Technical access issues were directed to the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Health
Next opportunity: Support of Highway Research, Development and Deployment Activities
Previous opportunity: Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 12 063
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 12 063) also looked into and applied for these:
| Funding Opportunity |
|---|
| Public Health Conference Support Program Apply for CDC RFA EH12 1201 Funding Number: CDC RFA EH12 1201 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Research Grants for Preventing Violence and Violence Related Injury Apply for RFA CE 12 002 Funding Number: RFA CE 12 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Identifying Modifiable Protective Factors for Intimate Partner Violence or Sexual Violence Prevention Apply for RFA CE 12 003 Funding Number: RFA CE 12 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Regional Genetic and Newborn Screening Services Collaboratives Heritable Disorders Program Apply for HRSA 12 138 Funding Number: HRSA 12 138 Agency: Health Resources and Services Administration Category: Health Funding Amount: $600,000 |
| Healthy Start Initiative Eliminating Disparities in Perinatal Health (General Population) Apply for HRSA 12 016 Funding Number: HRSA 12 016 Agency: Health Resources and Services Administration Category: Health Funding Amount: $750,000 |
| Healthy Start Initiative Eliminating Disparities in Perinatal Health (Border, Alaska, and Hawaii) Apply for HRSA 12 017 Funding Number: HRSA 12 017 Agency: Health Resources and Services Administration Category: Health Funding Amount: $750,000 |
| Green Housing Study Follow up Measurements of Housing Factors and Respiratory Health of Children located in Cincinnati and Boston (U01) Apply for RFA EH 12 001 Funding Number: RFA EH 12 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| HIV Early Intervention Services (EIS) Program Existing Geographic Service Areas (EISEGA) Apply for HRSA 12 076 Funding Number: HRSA 12 076 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Reducing Health Disparities among People with Intellectual Disabilities Apply for RFA DD 12 003 Funding Number: RFA DD 12 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Service Area Competition Additional Areas (Boydton, VA) Apply for HRSA 12 168 Funding Number: HRSA 12 168 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| State Implementation Grants for Systems of Services for Children and Youth with Special Health Care Needs (CYSHCN) Apply for HRSA 12 049 Funding Number: HRSA 12 049 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| New England Region AIDS Education and Training Center Program(s) (AETC) Apply for HRSA 12 124 Funding Number: HRSA 12 124 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Network and Infrastructure Support for Development of Interdisciplinary Aging Research (R24) Apply for PA 12 064 Funding Number: PA 12 064 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Human Heredity and Health in Africa (H3Africa) H3Africa Biorepository Grants (UH2/UH3) Apply for RFA RM 12 003 Funding Number: RFA RM 12 003 Agency: National Institutes of Health Category: Health Funding Amount: $115,000 |
| HIV Innovations for Improved Patient Outcomes for Priority Populations Apply for 674 12 000003 Funding Number: 674 12 000003 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $15,000,000 |
| Public Health Traineeships Apply for HRSA 12 005 Funding Number: HRSA 12 005 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Faculty Development in General, Pediatric, and Public Health Dentistry and Dental Hygiene Apply for HRSA 12 109 Funding Number: HRSA 12 109 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Training Programs for Critical HIV Research Infrastructure for Low and Middle Income Country Institutions (G11) Apply for PAR 12 069 Funding Number: PAR 12 069 Agency: National Institutes of Health Category: Health Funding Amount: $92,000 |
| Limited Competition Planning Grant for Fogarty HIV Research Training Program for Low and Middle Income Country Institutions (D71) Apply for PAR 12 070 Funding Number: PAR 12 070 Agency: National Institutes of Health Category: Health Funding Amount: $28,000 |
| Grants to States to Support Oral Health Workforce Activities Apply for HRSA 12 028 Funding Number: HRSA 12 028 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 12 063", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.